Sindrome neuroleptico maligno / Neuroleptic malignant syndrome
Iatreia
;
2(2): 161-164, ago. 1989.
Article
in Spanish
| LILACS
| ID: lil-84308
RESUMEN
El sindrome neuroleptico maligno (SNM) es una complicacion rara, idiosincratica y potenciamente fatal, relacionanda con el uso de drogas que afectan el sistema dopaminergico; su cuadro clinico consiste en sintomas extrapiramidales, signos de disfuncion autonomica y trastornos en el estado de conciencia, asociados a leucocitosis y a cifras muy elevadas de creatinina fosioquinasa. Reportamos el caso de un hombre de 32 anos que preesento un sindrome catatonico severo despues del uso intrahospitalario de antipsicoticos potentes a altas dosis para el control de una depresion psicotica. Se discuten las caracteristicas clinicas del paciente y los hallazgos comunes en el SNM
ABSTRACT
The Neuroleptic Malignant Syndrome (NMS) Is a rare, idiosyncratic and potentially fatal complication of therapy with many drugs affecting the dopaminergic system; It Includes extrapyramidal symptoms, signs of autonomic dysfunction, disorders of consciousness, leucocytosis and an increase in serum creatine phosphokinase .We report the case of a 32 years old man, who developed a severe catatonic syndrome after receiving high doses of potent neuroleptics to control a psychotic depression. Clinical features of this case and common findings of NMS are discussed
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Neuroleptic Malignant Syndrome
Type of study:
Diagnostic study
Limits:
Adult
/
Humans
/
Male
Country/Region as subject:
South America
/
Colombia
Language:
Spanish
Journal:
Iatreia
Journal subject:
Medicine
Year:
1989
Type:
Article
Affiliation country:
Colombia
Institution/Affiliation country:
Universidad de Antioquia/CO
Similar
MEDLINE
...
LILACS
LIS